San Francisco, California 94118

  • Child Behavior Problem

Purpose:

Maternal depression influences the development of children's behavior problems and vice versa; however most interventions singularly address maternal depression or children's behavior problems rather than both. This project assesses the efficacy of an intervention that treats both mothers and children in an integrated manner. Effects are expected to disrupt the reciprocal relations that perpetuate maternal and child mental health problems over time.


Study summary:

The proposed project is a pilot randomized controlled trial to evaluate the effectiveness of an integrated intervention that dually treats maternal depressive symptoms and offspring behavior problems. Families (n = 40 mothers and their 2-to-4 year-old children) will be randomized to receive 10 sessions of ABC or 10 sessions of ABC+D in their home. ABC+D is an expanded version of ABC that additionally treats maternal depressive symptoms using Mothers and Babies adapted for mothers of toddlers. The specific aims of this proposed project are: Aim 1. Collect preliminary data on the feasibility and acceptability of ABC+D in preparation for a small pilot randomized controlled trial (RCT). Aim 2. Conduct a small pilot RCT to examine the effectiveness of ABC and ABC+D Aim 3: Assess the overall acceptability (mother- and provider-rated), appropriateness (mother- and provider-rated), and feasibility (provider-rated) of ABC+D. Mothers will also rate their satisfaction with each session and the degree to which it was helpful, interesting, and comprehensible.


Criteria:

Inclusion Criteria: 1. Mothers 18 years of age or older with heightened depressive symptoms as determined by a score of 16 or higher on the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R) 2. Biological children (of mothers described above) between 2 and 4 years old with heightened behavior problems as determined by a score of 18 or higher on the Early Childhood Screening Assessment (ECSA) 3. English- or Spanish-speaking Exclusion Criteria: 1. Self-reported history of psychosis or active suicidality as defined by self-report of a specific suicide plan or recent attempt 2. Child diagnosis of autism


NCT ID:

NCT05096611


Primary Contact:

Principal Investigator
Danielle Roubinov, PhD
University of California, San Francisco

Danielle Roubinov, PhD
Phone: 415-476-2259
Email: danielle.roubinov@ucsf.edu


Backup Contact:

N/A


Location Contact:

San Francisco, California 94118
United States



There is no listed contact information for this specific location.

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: July 01, 2022

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.